Analyst firms · Raymond James · FGEN
Raymond James FGEN price target and rating history
FibroGen Inc (FGEN) · Health Care
Raymond James rates FibroGen Inc (FGEN) Mkt Perform with a $35 price target, as of its latest action on Jun 26, 2023. It has published 3 rating actions on FGEN since August 2021, including 2 upgrades and 1 downgrade.
- Current rating
- Mkt Perform
- Price target
- $35
- Median target, all firms
- Too few
- Actions on FGEN
- 3
Every Raymond James rating on FGEN
- Jun 26, 2023
- Jan 26, 2023
- Aug 20, 2021
Questions about Raymond James and FGEN
- What is Raymond James's price target for FGEN?
- Raymond James's latest stated price target for FibroGen Inc (FGEN) is $35, from its action on Jan 26, 2023.
- What is Raymond James's rating on FGEN?
- Raymond James rates FGEN Mkt Perform, a neutral rating, as of Jun 26, 2023.
- When did Raymond James last change its view on FGEN?
- On Jun 26, 2023, Raymond James downgrades to Mkt Perform from Outperform.
More FGEN rating histories
All Raymond James ratingsFGEN news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.